MTS2: Myopia (near-sightedness) in Young Children - Clinical Trial
What is the Purpose of this Study?
This study is being done to find out if atropine eyedrops (0.05% atropine, 99.95% inactive solution) and/or special eyeglass lenses are an effective strategy to slow down the progression of myopia for young children with nearsightedness.
Myopia (Nearsightedness) in Children
Who Can Participate in the Study?
Children ages 5-11 who:
- Have myopia
- Need to wear eye glasses regularly
- Do not have an allergy to atropine
For more information, contact the study team at corren.white@duke.edu.
What is Involved?
If you choose to have your child join this study, they will participate for about two and a half years. You and your child will come in for a study visit every three months. Half of the visits will be eye exams. The other half will be eyedrop pickup visits where your child won't see the eye doctor.
Your child will also have five visits to get fitted with new study glasses. The study will involve testing how well children can see, how well their eyes focus, and how nearsighted their eyes are. We will also ask your child to answer questions about how well they can see in their everyday activities.
Study Details
